March 28th 2025
In this CME article, learn more about the common neuropsychiatric sequelae of post-acute sequelae of COVID-19, the underlying neurobiological mechanisms, and evidence-based treatments and interventions.
Expert Perspectives in the Recognition and Management of Postpartum Depression
View More
Southern California Psychiatry Conference
July 11-12, 2025
Register Now!
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
BURST CME™ Part I: Understanding the Impact of Huntington’s Disease
View More
Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists
View More
Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease
View More
Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea
View More
Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment
View More
PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia
View More
Southern Florida Psychiatry Conference
November 21-22, 2025
Register Now!
Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?
View More
Optimizing Care for Patients With Tardive Dyskinesia
View More
Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia
View More
Repetitive Transcranial Magnetic Stimulation in Depression: A Changing Landscape
June 19th 2013Clinicians can feel confident in the evidence base when referring patients with a moderate level of treatment resistance for rTMS. Preliminary results suggest that deep rTMS may be an effective option in patients who have failed to respond to more than one antidepressant treatment.
Read More
ABPN Faculty Fellowship Announced
June 18th 2013The Directors of the ABPN have established a Faculty Fellowship Program to support the development of innovative education and evaluation projects that promote effective learning by residents, fellows, and practicing psychiatrists and neurologists.
Read More
Genetic Testing for Psychiatric Disorders: Its Current Role in Clinical Psychiatric Practice
June 12th 2013Genetics seems to be a subject of particular interest for everyone. This article explores how the current state of knowledge regarding genetics might be used to help psychiatrists diagnose psychiatric disorders or predict their onset.
Read More
Psychiatric Epigenetics: A Key to the Molecular Basis of and Therapy for Psychiatric Disorders
June 11th 2013The major challenges for epigenetic therapies are target specificity of the drugs-an issue that is also true for most of the currently used drugs in medicine, especially in psychiatry.
Read More
Deep Brain Stimulation: Evidence Based Science or Wishful Thinking?
May 28th 2013Because of new imaging techniques and advances in our understanding of neurophysiology, neurological and psychiatric disorders are increasingly being recognized as disorders of circuit functions in the brain. Using techniques such as DBS, neurosurgeons are able to pinpoint malfunctioning circuits and to recalibrate them.
Read More
Comorbidity In Psychiatric Disorders: A Literature Review
January 19th 2013A list of recent articles highlighting the complexity of psychiatric and systemic illness, both in terms of overlapping clinical presentation and in the degrees to which systemic illness and psychiatric illness affect each other.
Read More
Deep Brain Stimulation: New Promise in Alzheimer Disease and Depression?
December 13th 2012The evolution of deep brain stimulation for various neuropsychiatric disorders results from advances in structural and functional brain imaging, increased understanding of neurocircuitry of the brain, and improvements in neurosurgical techniques and equipment.
Read More
Minding Our Zeros and Ones: Are Psychiatrists Ready for Neurotechnology?
November 3rd 2012Neurotechnology refers to the science of applying our emerging understanding of the brain, consciousness, thought, and higher-order activities of the mind into developing technologies. The tools of neurotechnology, however, are not new for psychiatrists.
Read More
Coming Along With the DSM-5: Hybrid Models of Psychiatric Diagnosis
September 12th 2012Do not be surprised if you hear more about hybrid models of psychiatric diagnoses included in DSM-5. The categorical and dimensional model approaches are 2 sides of the same coin as you look at the same patient from 2 different angles.
Read More
Study Reports TMS Therapy Helps Patients With MDD
May 16th 2012New data show that patients with unipolar, non-psychotic major depressive disorder (MDD) receiving transcranial magnetic stimulation (TMS) achieved significant improvements in both depression symptoms and in quality of life measurements.
Read More
Traumatic Brain Injury and Therapeutic Creativity
April 16th 2012After Lord Michel Eyquem de Montaigne suffered a traumatic brain injury and PTSD from a near fatal horseback riding accident, he retired from public life, secluded himself in one of the towers of his château, and devoted himself to writing.
Read More
Mild Cognitive Impairment-An Added Value to Patient and Physician
February 29th 2012While there are currently no treatments for AD, it is important to examine what we are treating. By the time AD is diagnosed by clinical symptoms, 8 to possibly 15 years of pathological damage has already occurred.
Read More